Literature DB >> 15536207

Beyond the signal sequence: protein routing in health and disease.

Cecilia Castro-Fernández1, Guadalupe Maya-Núñez, P Michael Conn.   

Abstract

Receptors, hormones, enzymes, ion channels, and structural components of the cell are created by the act of protein synthesis. Synthesis alone is insufficient for proper function, of course; for a cell to operate effectively, its components must be correctly compartmentalized. The mechanism by which proteins maintain the fidelity of localization warrants attention in light of the large number of different molecules that must be routed to distinct subcellular loci, the potential for error, and resultant disease. This review summarizes diseases known to have etiologies based on defective protein folding or failure of the cell's quality control apparatus and presents approaches for therapeutic intervention.

Mesh:

Substances:

Year:  2004        PMID: 15536207     DOI: 10.1210/er.2004-0010

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  32 in total

Review 1.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

2.  Rescue of misrouted GnRHR mutants reveals its constitutive activity.

Authors:  Jo Ann Janovick; Irina D Pogozheva; Henry I Mosberg; Anda Cornea; P Michael Conn
Journal:  Mol Endocrinol       Date:  2012-05-17

3.  Refolding of misfolded mutant GPCR: post-translational pharmacoperone action in vitro.

Authors:  Jo Ann Janovick; Shaun P Brothers; Anda Cornea; Eugene Bush; Mark T Goulet; Wallace T Ashton; Daryl R Sauer; Fortuna Haviv; Jonathan Greer; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2007-05-03       Impact factor: 4.102

Review 4.  Melanotrope cells as a model to understand the (patho)physiological regulation of hormone secretion.

Authors:  R Vàzquez-Martínez; J R Peinado; D Cruz-García; A Ruiz-Navarro; F Gracia-Navarro; Y Anouar; M C Tonon; H Vaudry; J P Castaño; M M Malagón
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

Review 5.  Assay strategies for identification of therapeutic leads that target protein trafficking.

Authors:  P Michael Conn; Timothy P Spicer; Louis Scampavia; Jo Ann Janovick
Journal:  Trends Pharmacol Sci       Date:  2015-06-08       Impact factor: 14.819

Review 6.  Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; James A Dias; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2013-06-24       Impact factor: 4.102

Review 7.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

8.  Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapy.

Authors:  Jo Ann Janovick; M David Stewart; Darla Jacob; L D Martin; Jian Min Deng; C Allison Stewart; Ying Wang; Anda Cornea; Lakshmi Chavali; Suhujey Lopez; Shoukhrat Mitalipov; Eunju Kang; Hyo-Sang Lee; Pulak R Manna; Douglas M Stocco; Richard R Behringer; P Michael Conn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

Review 9.  Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Trends Endocrinol Metab       Date:  2009-12-11       Impact factor: 12.015

10.  Molecular mechanism of action of pharmacoperone rescue of misrouted GPCR mutants: the GnRH receptor.

Authors:  Jo Ann Janovick; Akshay Patny; Ralph Mosley; Mark T Goulet; Michael D Altman; Thomas S Rush; Anda Cornea; P Michael Conn
Journal:  Mol Endocrinol       Date:  2008-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.